The Journal of Pediatrics
Volume 156, Issue 5 , Pages 828-831 , May 2010

Misdiagnosis in Fabry Disease

This work was presented in part at the 60th annual meeting of the American Academy of Neurology, Chicago, IL, April, 2008. The authors declare no conflicts of interest.

  • Cintia L. Marchesoni, MD

      Affiliations

    • Neurology Department, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
    • ,
  • Norma Roa

      Affiliations

    • Hematology Service, Instituto Médico Quilmes, Quilmes, Argentina
    • ,
  • Ana María Pardal, MD

      Affiliations

    • Neurology Department, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
    • ,
  • Pablo Neumann, MD

      Affiliations

    • Nephrology Department, Hospital Italiano, La Plata, Argentina
    • ,
  • Guillermo Cáceres, MD

      Affiliations

    • Biochemistry Laboratory, Hospital Interzonal Pinamar, Pinamar, Argentina
    • ,
  • Pablo Martínez, Bioch

      Affiliations

    • Pediatric Service, Hospital Interzonal de Bahía Blanca, Bahía Blanca, Argentina
    • ,
  • Isaac Kisinovsky, MD

      Affiliations

    • Hematology Service, Instituto Médico Quilmes, Quilmes, Argentina
    • ,
  • Silvia Bianchi, MD

      Affiliations

    • Pediatric Service, Centro Fabry de Tucumán, Tucumán, Argentina
    • ,
  • Ana Lía Tarabuso, MD

      Affiliations

    • Dermatology Service, CEAL Centro Médico, Chubut, Trelew, Argentina
    • ,
  • Ricardo C. Reisin, MD

      Affiliations

    • Neurology Department, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
    • Corresponding Author InformationReprint requests: Ricardo C. Reisin, Neurology Department, Hospital Británico, Perdriel 74, Buenos Aires 1280, Argentina.

Received 19 April 2009 ,Revised 2 December 2009 ,Accepted 8 February 2010.

References 

  1. Sweeley CC, Klionsky B. Fabry's disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem. 1963;238:3148–3150
  2. Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA. 2008;105:2812–2817
  3. MacDermot KD, Holmes A, Minners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001;38:750–760
  4. MacDermot KD, Holmes A, Minners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001;38:769–775
  5. Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34:236–242
  6. Hollak CE, Vedder AC, Linthorst GE, Aerts JM. Novel therapeutic targets for the treatment of Fabry disease. Expert Opin Ther Targets. 2007;11:821–833
  7. Wraith JE, Tylki-Szymanska A, Guffon N, Lien YH, Tsimaratos M, Vellodi A, et al. Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease. J Pediatr. 2008;152:563–570
  8. Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sunder-Plassmann G, et al. Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr. 2006;95:86–92
  9. Ries M, Clarke JT, Whybra C, Timmons M, Robinson C, Schlaggar BL, et al. Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics. 2006;118:924–932
  10. Masson C, Cissé I, Simon V, Insalaco P, Audran M. Fabry disease: a review. Joint Bone Spine. 2004;71:381–383
  11. Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatr. 2004;144(Suppl):S20–S26
  12. Liston EH, Levine MD, Philippart M. Psychosis in Fabry disease and treatment with phenoxybenzamine. Arch Gen Psychiatry. 1973;29:402–403
  13. Grewal RP. Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry Med. 1993;23:307–312
  14. Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J. Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet. 2004;14:199–201
  15. Birklein F. Mechanisms of neuropathic pain and their importance in Fabry disease. Acta Paediatr Suppl. 2002;91:34–37
  16. Tan SV, Lee PJ, Walters RJ, Mehta A, Bostock H. Evidence for motor axon depolarization in Fabry disease. Muscle Nerve. 2005;32:548–551
  17. Hoffmann B, Beck M, Sunder-Plassmann G, Borsini W, Ricci R, Mehta A, et al. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy-a retrospective analysis from the Fabry Outcome Survey. Clin J Pain. 2007;23:535–542
  18. Paira SO, Roverano S, Iribas JL, Barceló HA. Joint manifestations of Fabry's disease. Clin Rheumatol. 1992;11:562–565
  19. Manger B, Mengel E, Schaefer R. Rheumatologic aspects of lysosomal storage diseases. Clin Rheumatol. 2007;26:335–341
  20. Atar D, Lehman WB, Grant AD. Growing pains. Orthop Rev. 1991;20:133–136
  21. Hopkin R, Bissler J, Banikazemi M, Clarke L, Eng G, Germain D, et al. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res. 2009;64:550–555
  22. Hoffmann B, Schwarz M, Mehta A, Keshav S. Fabry Outcome Survey European Investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy. Clin Gastroenterol Hepatol. 2007;5:1447–1453
  23. Alfvén G. One hundred cases of recurrent abdominal pain in children: diagnostic procedures and criteria for a psychosomatic diagnosis. Acta Paediatr. 2003;92:43–49
  24. Apley J. The Child with Abdominal Pains. 2nd ed.. Oxford, UK: Blackwell Scientific; 1975;
  25. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100:1868–1875
  26. Lake AM. Chronic abdominal pain in childhood: diagnosis and management. Am Fam Physician. 1999;59:1823–1830
  27. Frank F, Stricker T, Stallmach T, Braegger CP. Helicobacter pylori infection in recurrent abdominal pain. J Pediatr Gastroenterol Nutr. 2000;31:424–427
  28. Hyams JS. Chronic abdominal pain caused by sorbitol malabsorption. J Pediatr. 1982;100:772–773
  29. Della Giovanna P. Del angioqueratoma a la enfermedad de Fabry. Dermatol Arg. 2004;4:263–269
  30. Möhrenschlager M, Braun-Falco M, Ring J, Abeck D. Fabry disease: recognition and management of cutaneous manifestations. Am J Clin Dermatol. 2003;4:189–196
  31. Metha A. New developments in the management of Anderson-Fabry disease. QJM. 2002;95:647–653
  32. Larralde M, Luna P. In:  Wolff K,  Goldsmith LK,  Katz SI editor. Fabry disease in Fitzpatrick's Dermatology in General Medicine. 7th ed. New York: McGraw-Hill; 2008;p. 1281–1288
  33. Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, et al. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab. 2008;93:112–128

PII: S0022-3476(10)00136-8

doi: 10.1016/j.jpeds.2010.02.012

The Journal of Pediatrics
Volume 156, Issue 5 , Pages 828-831 , May 2010

Article Tools

* Image Usage & Resolution